OneDigital Investment Advisors LLC bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 1,863 shares of the company’s stock, valued at approximately $900,000.
Several other institutional investors have also made changes to their positions in ALAB. Glenmede Trust Co. NA grew its position in Astera Labs by 2.7% during the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock worth $209,000 after buying an additional 51 shares in the last quarter. Lido Advisors LLC raised its holdings in Astera Labs by 0.5% in the 4th quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after acquiring an additional 57 shares in the last quarter. Goldstein Advisors LLC lifted its position in shares of Astera Labs by 5.8% during the 4th quarter. Goldstein Advisors LLC now owns 1,611 shares of the company’s stock valued at $268,000 after acquiring an additional 88 shares during the period. Bell Investment Advisors Inc bought a new stake in shares of Astera Labs during the 2nd quarter valued at $43,000. Finally, Great Valley Advisor Group Inc. grew its holdings in shares of Astera Labs by 2.2% during the 2nd quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock worth $372,000 after purchasing an additional 90 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors.
Insiders Place Their Bets
In other news, Director Manuel Alba sold 136,974 shares of the stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total value of $60,543,877.74. Following the completion of the transaction, the director owned 1,287,524 shares of the company’s stock, valued at approximately $569,098,483.24. This represents a 9.62% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the stock in a transaction dated Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the completion of the transaction, the chief operating officer directly owned 5,064,213 shares of the company’s stock, valued at $1,470,141,033.90. This trade represents a 7.32% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 631,979 shares of company stock worth $215,479,247 in the last ninety days. Insiders own 10.40% of the company’s stock.
Astera Labs Stock Performance
Astera Labs (NASDAQ:ALAB – Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The company had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.Astera Labs’s revenue was up 104.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, research analysts forecast that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.
Analyst Ratings Changes
ALAB has been the topic of a number of recent analyst reports. Evercore restated an “outperform” rating and issued a $297.00 price target on shares of Astera Labs in a research report on Tuesday, May 19th. TD Cowen cut their price objective on shares of Astera Labs from $425.00 to $375.00 and set a “hold” rating for the company in a research report on Wednesday, August 5th. Zacks Research upgraded shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. Barclays raised their target price on shares of Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a report on Monday, July 20th. Finally, Susquehanna boosted their target price on shares of Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research report on Friday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $333.00.
Check Out Our Latest Research Report on ALAB
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Stories
- Five stocks we like better than Astera Labs
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
